Follow
Masaru Kanekiyo
Masaru Kanekiyo
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Verified email at nih.gov
Title
Cited by
Cited by
Year
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ...
Nature 499 (7456), 102-106, 2013
8992013
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ...
Nature medicine 21 (9), 1065-1070, 2015
6872015
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
D Corti, J Misasi, S Mulangu, DA Stanley, M Kanekiyo, S Wollen, ...
Science 351 (6279), 1339-1342, 2016
4232016
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ...
Science translational medicine 7 (309), 309ra162-309ra162, 2015
4032015
Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site
M Kanekiyo, W Bu, MG Joyce, G Meng, JRR Whittle, U Baxa, T Yamamoto, ...
Cell 162 (5), 1090-1100, 2015
3512015
Evaluation of candidate vaccine approaches for MERS-CoV
L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ...
Nature communications 6 (1), 7712, 2015
3422015
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses
MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ...
Cell 166 (3), 609-623, 2016
3292016
High-throughput mapping of B cell receptor sequences to antigen specificity
I Setliff, AR Shiakolas, KA Pilewski, AA Murji, RE Mapengo, K Janowska, ...
Cell 179 (7), 1636-1646. e15, 2019
2842019
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ...
Nature medicine 24 (4), 408-416, 2018
2732018
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ...
Nature immunology 20 (3), 362-372, 2019
2682019
Quadrivalent influenza nanoparticle vaccines induce broad protection
S Boyoglu-Barnum, D Ellis, RA Gillespie, GB Hutchinson, YJ Park, ...
Nature 592 (7855), 623-628, 2021
2452021
Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages
JRR Whittle, AK Wheatley, L Wu, D Lingwood, M Kanekiyo, SS Ma, ...
Journal of virology 88 (8), 4047-4057, 2014
2302014
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
J Misasi, MSA Gilman, M Kanekiyo, M Gui, A Cagigi, S Mulangu, D Corti, ...
Science 351 (6279), 1343-1346, 2016
2102016
Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid …
L Wang, W Shi, JD Chappell, MG Joyce, Y Zhang, M Kanekiyo, ...
Journal of virology 92 (10), 10.1128/jvi. 02002-17, 2018
1822018
Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein-Barr virus in B cells and epithelial cells
W Bu, MG Joyce, H Nguyen, DV Banh, F Aguilar, Z Tariq, ML Yap, ...
Immunity 50 (5), 1305-1316. e6, 2019
1492019
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
AM Killikelly, M Kanekiyo, BS Graham
Scientific reports 6 (1), 34108, 2016
1462016
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
G Ueda, A Antanasijevic, JA Fallas, W Sheffler, J Copps, D Ellis, ...
Elife 9, e57659, 2020
1442020
Activation dynamics and immunoglobulin evolution of pre-existing and newly generated human memory B cell responses to influenza hemagglutinin
SF Andrews, MJ Chambers, CA Schramm, J Plyler, JE Raab, M Kanekiyo, ...
Immunity 51 (2), 398-410. e5, 2019
1282019
Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages
KS Corbett, SM Moin, HM Yassine, A Cagigi, M Kanekiyo, ...
MBio 10 (1), 10.1128/mbio. 02810-18, 2019
1122019
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
KV Houser, GL Chen, C Carter, MC Crank, TA Nguyen, MC Burgos Florez, ...
Nature medicine 28 (2), 383-391, 2022
1082022
The system can't perform the operation now. Try again later.
Articles 1–20